UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel Inflammatory Prognostic Markers in Lung Cancer Patients Treated with Definitive Chemoradiotherapy

Genel tip dergisi, 2022-12, Vol.32 (6), p.646-651

2022

Volltextzugriff (PDF)

Acute sunitinib neurotoxicity

Cancer treatment and research communications, 2021, Vol.27, p.100366, Article 100366

2021

Volltextzugriff (PDF)

Advanced Hepatocellular Cancer Treated with Sorafenib and Novel Inflammatory Markers

Journal of gastrointestinal cancer, 2023-03, Vol.54 (1), p.11-19

2023

Volltextzugriff (PDF)

Sonographic and Electrodiagnostic Evaluations in Patients With Aromatase Inhibitor–Related Arthralgia

Journal of clinical oncology, 2009-10, Vol.27 (30), p.4955-4960

2009

Volltextzugriff (PDF)

Breast cancer subtypes and outcomes of central nervous system metastases

Breast (Edinburgh), 2011-12, Vol.20 (6), p.562-567

2011

Volltextzugriff (PDF)

Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis

Leukemia & lymphoma, 2009-01, Vol.50 (3), p.357-365

2009

Volltextzugriff (PDF)

Efficacy of Anastrozole on Local Recurrence in Patients With Favorable Early Breast Cancer

International journal of radiation oncology, biology, physics, 2007-12, Vol.69 (5), p.1651-1651

2007

Volltextzugriff (PDF)

Efficacy of Chemotherapy for Brain Metastases From Breast Carcinoma: In Regard to Le Scodan et al. ( Int J Radiat Oncol Biol Phys 2007;69:839–845)

International journal of radiation oncology, biology, physics, 2008-04, Vol.70 (5), p.1615-1615

2008

Volltextzugriff (PDF)

The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor–positive/progesterone receptor–negative/Her-2/neu receptor–positive pattern

The American journal of surgery, 2007-08, Vol.194 (2), p.272-273

2007

Volltextzugriff (PDF)

Rituximab-related viral infections in lymphoma patients

Leukemia & lymphoma, 2007-01, Vol.48 (7), p.1307-1312

2007

Volltextzugriff (PDF)

Metastatic granular cell tumor: A case report and review of the literature

Acta oncologica, 2006, Vol.45 (1), p.91-94

2006

Volltextzugriff (PDF)

Outcomes with first-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs physician’s choice combination chemotherapy (combo CT) by age in pre/perimenopausal patients (pts) with aggressive HR+/HER2− advanced breast cancer (ABC): A subgroup analysis of the RIGHT Choice trial

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1063-1063

2023

Volltextzugriff (PDF)

Potential targeted therapy options in the management of basal cell subtype of breast carcinoma

Human pathology, 2007-12, Vol.38 (12), p.1869-1869

2007

Volltextzugriff (PDF)

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC

Journal of oncology pharmacy practice, 2024-04, p.10781552241241004-10781552241241004

2024

Volltextzugriff (PDF)

Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e20512-e20512

2024

Volltextzugriff (PDF)

Association of CagA and VacA presence with ulcer and non-ulcer dyspepsia in a Turkish population

World journal of gastroenterology : WJG, 2003-07, Vol.9 (7), p.1580

2003

Volltextzugriff (PDF)

Characteristics of Breast Cancer Patients with Central Nervous System Metastases: A Single-Center Experience

Journal of the National Medical Association, 2008-05, Vol.100 (5), p.521-533

2008

Volltextzugriff (PDF)

Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Journal of clinical oncology, 2024-08, Vol.42 (23), p.2812-2821

2024

Volltextzugriff (PDF)

The effect of front-line chemotherapy on overall survival in patients with malignant pleural mesothelioma

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e18560-e18560

2013

Volltextzugriff (PDF)

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wi̇ld-type patients treated with biologics second-line mCRC

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e15562-e15562

2022

Volltextzugriff (PDF)

Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e12610-e12610

2022

Volltextzugriff (PDF)

Clinical Characteristics and Outcomes of Cancer Cases Among Syrian Refugees From Southern Turkey

JAMA network open, 2023-05, Vol.6 (5), p.e2312903-e2312903

2023

Volltextzugriff (PDF)

Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours-results from a Turkish multi-centre study

Japanese journal of clinical oncology, 2024-05, Vol.54 (5), p.562-568

2024

Volltextzugriff (PDF)

Is excision repair cross-complementation Group1 expression a biological marker in nasopharynx carcinoma?

Journal of cancer research and therapeutics, 2019-07, Vol.15 (3), p.550-555

2019

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(92)

Sprache

Englisch
(91)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Novel Inflammatory Prognostic Markers in Lung Cancer Patients Treated with Definitive Chemoradiotherapy

Acute sunitinib neurotoxicity

Advanced Hepatocellular Cancer Treated with Sorafenib and Novel Inflammatory Markers

Sonographic and Electrodiagnostic Evaluations in Patients With Aromatase Inhibitor–Related Arthralgia

Breast cancer subtypes and outcomes of central nervous system metastases

Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis

Efficacy of Anastrozole on Local Recurrence in Patients With Favorable Early Breast Cancer

Efficacy of Chemotherapy for Brain Metastases From Breast Carcinoma: In Regard to Le Scodan et al. ( Int J Radiat Oncol Biol Phys 2007;69:839–845)

The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor–positive/progesterone receptor–negative/Her-2/neu receptor–positive pattern

Rituximab-related viral infections in lymphoma patients

Metastatic granular cell tumor: A case report and review of the literature

Outcomes with first-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs physician’s choice combination chemotherapy (combo CT) by age in pre/perimenopausal patients (pts) with aggressive HR+/HER2− advanced breast cancer (ABC): A subgroup analysis of the RIGHT Choice trial

Potential targeted therapy options in the management of basal cell subtype of breast carcinoma

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC

Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study

Association of CagA and VacA presence with ulcer and non-ulcer dyspepsia in a Turkish population

Characteristics of Breast Cancer Patients with Central Nervous System Metastases: A Single-Center Experience

Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

The effect of front-line chemotherapy on overall survival in patients with malignant pleural mesothelioma

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wi̇ld-type patients treated with biologics second-line mCRC

Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study)

Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study

Clinical Characteristics and Outcomes of Cancer Cases Among Syrian Refugees From Southern Turkey

Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours-results from a Turkish multi-centre study

Is excision repair cross-complementation Group1 expression a biological marker in nasopharynx carcinoma?

Suchergebnisse filtern